A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus

Clinical trial NCT01235039 · COMPLETED

Trial details

NCT number: NCT01235039
Sponsor: Biodel
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2009-07-01
Primary completion: 2009-09-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.